Finally, zebrafish and human 3D organotypic models of psoriasis reveal the relevance of diabetic comorbidity in skin inflammation and suggest a therapeutic benefit of inhibiting GLUT1 and DPP4. The gene discussed is DPP4; the disease is psoriasis.